SCHEMBL7340276

SCHEMBL7340276

CCCc1cc2ccccc2s1.CCCc1cc2ccccc2s1

nearest known ligand 0.60

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.60
ASIC3 Q9UHC3 1/20 0.60
LOXL2 Q9Y4K0 1/20 0.60
ADRB2 P07550 1/20 0.59
AGXT P21549 1/20 0.55
ADRA1D P25100 2/20 0.45
IDH1 O75874 1/20 0.43
DRD2 P14416 1/20 0.43
SLC6A4 P31645 1/20 0.43
RAB9A P51151 1/20 0.43
MGLL Q99685 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6963172 1.00 CYP2A6 (0.60) CYP2A6ASIC3LOXL2ADRB2AGXT
SCHEMBL7345698 0.89 CYP2A6 (0.56) CYP2A6ASIC3LOXL2ADRB2AGXT
SCHEMBL346786 0.89 CYP2A6 (0.56) CYP2A6ASIC3LOXL2ADRB2AGXT
SCHEMBL368353 0.87 CYP2A6 (0.55) CYP2A6ASIC3LOXL2ADRB2AGXT
SCHEMBL24614167 0.85 CYP2A6 (0.53) CYP2A6ASIC3LOXL2ADRB2AGXT
SCHEMBL9347774 0.85 CYP2A6 (0.53) CYP2A6ASIC3LOXL2ADRB2AGXT
SCHEMBL1687607 0.85 CYP2A6 (0.53) CYP2A6ASIC3LOXL2ADRB2AGXT
SCHEMBL9347724 0.85 CYP2A6 (0.53) CYP2A6ASIC3LOXL2ADRB2AGXT
SCHEMBL31362124 0.84 CYP2A6 (0.56) CYP2A6ASIC3LOXL2ADRB2AGXT
SCHEMBL3413507 0.83 CYP2A6 (0.64) CYP2A6ASIC3LOXL2ADRB2AGXT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0819125-A1 THIENYL-, FURYL-, PYRROLYL- AND BIPHENYLSULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN TEXAS BIOTECHNOLOGY CORPORATION (US) 1998-01-21 EP disclosed
WO-1996031492-A1 THIENYL-, FURYL-, PYRROLYL- AND BIPHENYLSULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN TEXAS BIOTECHNOLOGY CORPORATION (US) 1996-10-10 WO disclosed